ALGS
Price
$9.43
Change
+$0.72 (+8.27%)
Updated
Jan 13, 04:59 PM (EDT)
Capitalization
53.6M
Intraday BUY SELL Signals
FTRE
Price
$17.37
Change
-$1.03 (-5.60%)
Updated
Jan 13, 04:59 PM (EDT)
Capitalization
1.7B
62 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALGS vs FTRE

Header iconALGS vs FTRE Comparison
Open Charts ALGS vs FTREBanner chart's image
Aligos Therapeutics
Price$9.43
Change+$0.72 (+8.27%)
Volume$400
Capitalization53.6M
Fortrea Holdings
Price$17.37
Change-$1.03 (-5.60%)
Volume$34.46K
Capitalization1.7B
ALGS vs FTRE Comparison Chart in %
ALGS
Daily Signal:
Gain/Loss:
FTRE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALGS vs. FTRE commentary
Jan 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and FTRE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 14, 2026
Stock price -- (ALGS: $8.71 vs. FTRE: $18.40)
Brand notoriety: ALGS and FTRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 149% vs. FTRE: 128%
Market capitalization -- ALGS: $53.6M vs. FTRE: $1.7B
ALGS [@Biotechnology] is valued at $53.6M. FTRE’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $116.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileFTRE’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • FTRE’s FA Score: 1 green, 4 red.
According to our system of comparison, FTRE is a better buy in the long-term than ALGS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 3 TA indicator(s) are bullish while FTRE’s TA Score has 3 bullish TA indicator(s).

  • ALGS’s TA Score: 3 bullish, 6 bearish.
  • FTRE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, FTRE is a better buy in the short-term than ALGS.

Price Growth

ALGS (@Biotechnology) experienced а +3.57% price change this week, while FTRE (@Biotechnology) price change was +10.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.80%. For the same industry, the average monthly price growth was +1.44%, and the average quarterly price growth was +42.28%.

Reported Earning Dates

FTRE is expected to report earnings on Mar 16, 2026.

Industries' Descriptions

@Biotechnology (+4.80% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FTRE($1.7B) has a higher market cap than ALGS($53.6M). FTRE YTD gains are higher at: 6.667 vs. ALGS (-6.545). ALGS has higher annual earnings (EBITDA): -84.01M vs. FTRE (-852.7M). FTRE has more cash in the bank: 131M vs. ALGS (99.1M). ALGS has less debt than FTRE: ALGS (6.07M) vs FTRE (1.19B). FTRE has higher revenues than ALGS: FTRE (2.76B) vs ALGS (2.65M).
ALGSFTREALGS / FTRE
Capitalization53.6M1.7B3%
EBITDA-84.01M-852.7M10%
Gain YTD-6.5456.667-98%
P/E RatioN/AN/A-
Revenue2.65M2.76B0%
Total Cash99.1M131M76%
Total Debt6.07M1.19B1%
TECHNICAL ANALYSIS
Technical Analysis
ALGSFTRE
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 26 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signal:
Gain/Loss:
FTRE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEBIX16.170.07
+0.43%
First Eagle Global Income Builder I
RYANX161.250.39
+0.24%
Rydex Nova A
FAIDX59.02N/A
N/A
Fidelity Advisor International Discv A
LPFCX4.81N/A
N/A
ALPS Global Opportunity C
DDERX15.83N/A
N/A
Nomura Wealth Builder R6

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with RGNX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
-3.22%
RGNX - ALGS
48%
Loosely correlated
+3.36%
ARWR - ALGS
47%
Loosely correlated
+2.12%
BEAM - ALGS
46%
Loosely correlated
+22.29%
SYRE - ALGS
46%
Loosely correlated
+7.15%
XNCR - ALGS
45%
Loosely correlated
+2.02%
More

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with BEAM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
+5.81%
BEAM - FTRE
45%
Loosely correlated
+22.29%
SYRE - FTRE
45%
Loosely correlated
+7.15%
TECH - FTRE
43%
Loosely correlated
+1.31%
ALGS - FTRE
41%
Loosely correlated
-3.22%
NTLA - FTRE
41%
Loosely correlated
+10.12%
More